Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

January 15, 2021

Brain 18F-FDG and 18F-Flumetamol PET Imaging of Fragile X-Associated Tremor Ataxia Syndrome

Clinical Nuclear Medicine
Ruggero BacchinStefano Tamburin
January 9, 2021
Review
Open Access

Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders

Molecular Psychiatry
Sébastien Delhaye, Barbara Bardoni
January 10, 2021
Open Access

STEP inhibition prevents Aβ-mediated damage in dendritic complexity and spine density in Alzheimer's disease

Experimental Brain Research
Manavi ChatterjeePaul J Lombroso
January 16, 2021
Open Access

The Effect of Tryptophan 2,3-Dioxygenase Inhibition on Kynurenine Metabolism and Cognitive Function in the APP23 Mouse Model of Alzheimer's Disease

International Journal of Tryptophan Research : IJTR
Fjh SorgdragerP P De Deyn
January 16, 2021

Nmnat1 Modulates Mitochondrial Oxidative Stress by Inhibiting Caspase-3 Signaling in Alzheimer's Disease

Journal of Molecular Neuroscience : MN
Huayu JiangZhiwen Yao
January 14, 2021
Preprint
Open Access

CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease

ResearchSquare
Simone Mwenda CrivelliPilar Martinez-Martinez
January 10, 2021
Open Access

Spatiotemporal analysis of soluble aggregates and autophagy markers in the R6/2 mouse model

Scientific Reports
M J Vijay KumarJames P Clement
January 13, 2021

Altered nociception in Alzheimer's disease is associated with STEP signaling

Pain
Zhung-Fu LeeIrene Hanjuo Cheng
January 16, 2021
Open Access

Spatial memory deficiency early in 6xTg Alzheimer's disease mouse model

Scientific Reports
Shinwoo KangKeun-A Chang
January 16, 2021
Open Access

Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease

International Journal of Molecular Sciences
Hyeon Jeong SeoByeong C Kim
January 12, 2021

Cornel Iridoid Glycoside Regulates Modification of Tau and Alleviates Synaptic Abnormalities in Aged P301S Mice

Current Medical Science
Cui-Cui YangLan Zhang

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-animal-models/8d4b2991-c4bd-47f2-ac26-3565c6d96f3b